When considering only the nonhypoxic (i.e., the nonnecrotic) volume, tumor masses from mice treated with scDb-hERG1-β1-TRAIL had a volume of roughly 70 mm3, meaning a roughly complete arrest in tumor growth, with an effect significantly stronger than in tumor masses from mice treated with scDb-hERG1-β1 (Fig. 6H). Here, TNFSF10 is linked to neoplasm.